⌘K

Login Start Free

Home/Filings/4/0001209191-22-007902

4//SEC Filing

Hollander David 4

Accession 0001209191-22-007902

CIK 0001337553other

View on SEC.gov Company Profile

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 8:40 PM ET

Size

4.8 KB

Accession

0001209191-22-007902

Insider Transaction Report

Form 4

Period: 2022-02-04

AERIE PHARMACEUTICALS INCAERI

Hollander David

Chief R&D Officer

Transactions

Tax Payment
Common Stock
2022-02-04$7.05/sh−927$6,535→ 30,749 total

Footnotes (1)

[F1]Reflects shares of Common Stock withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted Common Stock.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

AERIE PHARMACEUTICALS INC

CIK 0001337553

Entity typeother

Related Parties

1

filerCIK 0001793796

Filing Metadata

Form type: 4
Filed: Feb 7, 7:00 PM ET
Accepted: Feb 8, 8:40 PM ET
Size: 4.8 KB

View on SEC.gov